Basic and diluted net loss per share of common stock was calculated as follows (in thousands except per share amounts):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net loss	$	(2,911	)	$	(2,895	)	$	(6,432	)	$	(5,315	)
Denominator:
Weighted average shares used in computing net loss per share – basic and diluted		47,298,148			36,576,567			42,690,881			34,000,539
Net loss per share – basic and diluted	$	(0.06	)	$	(0.08	)	$	(0.15	)	$	(0.16	)

For the three and six months ended June 30, 2026 and 2025, the Company had a net loss and as such, all outstanding shares of potentially dilutive securities were excluded from the calculation of diluted net loss per share as the inclusion would be anti-dilutive.

Potentially dilutive securities not included in the computation of diluted net loss per share because to do so would be antidilutive are as follows (in common stock equivalent shares):


	As of June 30,
	2026		2025
Options to purchase common stock		6,449,232		936,657
Unvested restricted stock units		28,578		-
Common stock warrants		28,554,994		19,714,006
Total		35,032,804		20,650,663